Hugh Solvason
Clinical Trials
- A Twelve Month, Open-Label, Safety Trial of Flibanserin 50 Milligrams to 100 Milligrams Daily in Women with Hypoactive Sexual Desire Disorder Recruiting
- Repetitive Transcranial Magnetic Stimulation (rTMS) for treatment resistant bipolar depression No longer recruiting
- Treatment of Schizoaffective Disorder Using Mifepristone Terminated
- A safety and efficacy trial of flibanserin in premenopausal women with HSDD No longer recruiting
Help